Avenue Therapeutics Buys Baergic Bio, Beefs Up Central Nervous System-Focused Portfolio
Avenue Therapeutics Inc (NASDAQ:ATXI) acquired Baergic Bio Inc pursuant to the previously disclosed Share Contribution Agreement with its parent company, Fortress Biotech Inc (NASDAQ:FBIO).…